Video

Dr. Syan on new recharge-free sacral neuromodulation system for bladder/bowel dysfunction

Author(s):

Urology Times staff
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Raveen Syan, MD, discusses Axonics F15, an FDA-approved recharge-free sacral neuromodulation implantable neurostimulator for the treatment of patients with bladder and bowel dysfunction. Syan is an assistant professor of Clinical Urology at the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine.

      Related Videos
      Closeup of patient with prescription | Image Credit: © gpointstudio - stock.adobe.com
      Investigators characterize vibegron prescribing patterns for OAB
      Colin Goudelocke, MD, answers a question during a Zoom video interview
      Expert outlines advantages of batteryless sacral neuromodulation device
      Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI
      Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI
      Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
      Smaller size, patient control advantages of neurostimulator for OAB
      Batteryless neurostimulator found efficacious at 6-month follow-up
      Batteryless neurostimulator found efficacious at 6-month follow-up
      Colin Goudelocke, MD, answers a question during a Zoom video interview
      Colin Goudelocke, MD, on 6-month data for batteryless neurostimulator
      Vanita Gaglani, RPT, answers a question during a video interview
      A physical therapist’s advice for men with post-prostatectomy incontinence
      William Furuyama, MD, answers a question during a Zoom video interview
      William Furuyama, MD, on community factors’ influence on urinary incontinence
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Investigators explore social vulnerability and urinary incontinence
      Vanita Gaglani, RPT, answers a question during a video interview
      Vanita Gaglani, RPT, discusses books on post-prostatectomy incontinence and prostatitis
      Related Content
      Gene therapy shows encouraging efficacy for overactive bladder
      April 8th 2025

      Gene therapy shows encouraging efficacy for overactive bladder

      Hannah Clarke
      At week 12, patients in the URO-902 cohorts demonstrated significantly greater improvements in daily microuritions vs placebo.
      Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB
      March 21st 2022

      Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB

      Urology Times staff
      “This technique is feasible, it is very well tolerated, and there’s not much of a complication rate, so it appears to be very safe,” says Amy D. Dobberfuhl, MD, MS.
      FDA grants 510(k) clearance to Glean Urodynamics System
      April 2nd 2025

      FDA grants 510(k) clearance to Glean Urodynamics System

      Hannah Clarke
      "Glean will enable patients to void naturally, without catheters in place. I believe this advance will yield a better test that mimics actual symptoms," says Bilal I. Chughtai, MD.
      Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB
      March 18th 2022

      Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB

      Urology Times staff
      “We need to improve the fact that 75% of these patients are untreated [or] unmanaged and frustrated,” says Alexandra Rogers, MD.
      FDA greenlights pivotal trial of Voro Urologic Scaffold for postprostatectomy SUI
      March 4th 2025

      FDA greenlights pivotal trial of Voro Urologic Scaffold for postprostatectomy SUI

      Hannah Clarke
      The ARID II trial is assessing the safety and effectiveness of the device in men who are scheduled to undergo robotic-assisted radical prostatectomy.
      Pivotal study data show efficacy of percutaneous SNM device for UUI
      February 28th 2025

      Pivotal study data show efficacy of percutaneous SNM device for UUI

      Hannah Clarke
      Overall, 84.2% of patients achieved a 50% or greater reduction in urgent leaks.
      © 2025 MJH Life Sciences

      All rights reserved.